Glioblastoma Multiforme Grant

Altered peptide epitopes derived from the anti-apoptotic protein ‘survivin’ may stimulate effective anti-glioma immune responses

Principal Investigator: Michael Ciesielski, PhD

Institute: Roswell Park Cancer Institute

Initiative: Glioblastoma Multiforme Grant

Location: Buffalo, NY

Blockade of glioblastoma tumor progression by specific mRNA translation inhibition

Principal Investigator: David Wells, PhD

Institute: Yale University

Initiative: Glioblastoma Multiforme Grant

Location: New Haven, CT

Characterization of the antiglioma effect of icovira new oncolytic adenovirus

Principal Investigator: Juan Fueyo, MD

Institute: MD Anderson Cancer Center

Initiative: Glioblastoma Multiforme Grant

Location: Hanover, NH

Colony-forming Antibody Cell Array: A Novel Assay to Screen for Cancer Stem Cells in Human Glioblastoma Multiforme

Principal Investigator: Stephen Skirboll, MD

Institute: Stanford University

Initiative: Glioblastoma Multiforme Grant

Location: Stanford, CA

Combination of oncolytic measles virus derivatives and radiation therapy in the treatment of Glioblastoma Multiforme

Principal Investigator: Evanthia Galanis, MD

Institute: Mayo Clinic

Initiative: Glioblastoma Multiforme Grant

Location: Scottsdale, AZ

Identification of Molecular Drivers of Brain Tumor Stem Cell Functions Using a Lentiviral RNAi Screen

Principal Investigator: David M. Sabatini, M.D., Ph.D.

Institute: Whitehead Institute

Initiative: Glioblastoma Multiforme Grant

Location: Cambridge, MA

Identification of therapeutic targets in glioblastoma stem cells

Principal Investigator: Cho-Lea Tso, PhD

Institute: University of California, Los Angeles

Initiative: Glioblastoma Multiforme Grant

Location: Los Angeles, CA

Investigation of Mismatch Repair Pathway Inactivation in Chemoresistant Glioblastomas

Principal Investigator: Dan Cahill, MD, PhD

Institute: Massachusetts General Hospital

Initiative: Glioblastoma Multiforme Grant

Location: Boston, MA

Regional expression and functional role of inhibitors of apoptosis in human GBM

Principal Investigator: Abhijit Guha, MD, FRCSC, FACS

Institute: University of Toronto

Initiative: Glioblastoma Multiforme Grant

Location: Toronto, ON

Study of Brain Angiogenesis Inhibitor-1 in Gliomagenesis and Progression

Principal Investigator: Erwin Van Meir, PhD

Institute: Emory University

Initiative: Glioblastoma Multiforme Grant

Location: Atlanta, GA

Towards personalized medicine in neurooncology: multigene predictor of response in glioblastoma

Principal Investigator: Kenneth Aldape, MD

Institute: MD Anderson Cancer Center

Initiative: Glioblastoma Multiforme Grant

Location: Houston, TX

Validation of GSK-3 as an Anti-Invasive Target in Glioma

Principal Investigator: E. Antonio Chiocca, MD, PhD

Institute: Ohio State University

Initiative: Glioblastoma Multiforme Grant

Location: Columbus, OH

Anti-angiogenic treatment for enhancement of anti-tumor effects of oncolytic viruses

Principal Investigator: Balveen Kaur, PhD

Institute: Ohio State University

Initiative: Glioblastoma Multiforme Grant

Location: Columbus, OH

Principal Investigator: Balveen Kaur, PhD

Institute: Ohio State University

Initiative: Glioblastoma Multiforme Grant

Location: Columbus, OH

Share